Tarsus Pharmaceuticals
TARS
TARS
40 hedge funds and large institutions have $523M invested in Tarsus Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.71%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VC
Vivo Capital
Palo Alto,
California
|
+$134M |
2 |
RI
RTW Investments
New York
|
+$99M |
3 |
FM
Frazier Management
Seattle,
Washington
|
+$79.2M |
4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$70M |
5 |
PA
Perceptive Advisors
New York
|
+$53.6M |
Top Sellers
No sellers this quarter